Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shanmugavel Madasamy"'
Autor:
Alan H.B. Wu, Jasmine Villanueva, Shanmugavel Madasamy, Edward P. Amento, Umadevi Shivasubramani, Marty Bigos
Publikováno v:
The American Journal of Cardiology. 118:1187-1193
Statin drugs are leading medication prescribed for treatment of dyslipidemic patients aimed at preventing both primary and secondary incidences of atherosclerosis-related cardiovascular events. Statin drugs competitively inhibit HMG-CoA reductase enz
Autor:
Ravikumar Ponnusamy, J. Paul Robinson, Shreya Mathur, Jason Lundry, Elliott J. Mufson, Shanmugavel Madasamy, Angela Abrea, Ben Alderete, Sundar Shanmugavel, Alan H.B. Wu, Ahmad Salehi, Raymond Kong
Publikováno v:
Alzheimer's & Dementia. 14
Autor:
J. Paul Robinson, David Liu, Shanmugavel Madasamy, Raymond Kong, Alan H B Wu, Edward P. Amento, Benjamin Alderete, Jason Lundry
Publikováno v:
Journal of visualized experiments : JoVE, vol 2017, iss 129
Journal of Visualized Experiments : JoVE
Journal of Visualized Experiments : JoVE
Treatment of dyslipidemia patients with lipid-lowering drugs leads to a significant reduction in low-density lipoproteins (LDL) level and a low to moderate level of increase in high-density lipoprotein (HDL) cholesterol in plasma. However, a possible
Plaque array method and proteomics-based identification of biomarkers from Alzheimer's disease serum
Autor:
Vaishali Chaudhuri, Marty Bigos, Weiming Ruan, Alan H.B. Wu, Shanmugavel Madasamy, Benjamin Alderete, Christopher M. Adams, Edward P. Amento, Tim D. Knaak, Raymond Kong
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 441
Background Progressive accumulation of amyloid plaques in the regions of brain, carotid and cerebral arteries is the leading cause of Alzheimer's disease (AD) and related dementia in affected patients. The early identification of individuals with AD